Drug recall · April 17, 2019
Telmisartan and Amlodipine Tablets 80 mg/5 mg recall
Why: Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablets, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478 --- NDC 42291-795-30
- Lots / codes
Lots: 201916 Exp. 08/2019; 20092 Exp. 08/2019
- Quantity
- 397 bottles
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- AZ, CO
- Initiated
- April 3, 2019 · Voluntary: Firm initiated
- Classified
- April 11, 2019
- Reported
- April 17, 2019
- Ended
- May 7, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.